147 related articles for article (PubMed ID: 8737189)
1. Successful induction of spermatogenesis in a patient with hypogonadotropic hypogonadism following co-treatment with growth hormone.
Zalel Y; Manor M; Zadik Z; Shoham Z
Gynecol Endocrinol; 1996 Feb; 10(1):29-31. PubMed ID: 8737189
[No Abstract] [Full Text] [Related]
2. A prospective pilot study of co-treatment with growth hormone and gonadotropins for improving spermatogenesis in normogonadotropic patients with severe oligoteratoasthenospermia.
Zalel Y; Draysen E; Goldschmit R; Zadik Z; Shoham Z
Gynecol Endocrinol; 1996 Feb; 10(1):23-8. PubMed ID: 8737188
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism.
Burger HG; Baker HW
Ann N Y Acad Sci; 1984; 438():447-53. PubMed ID: 6442839
[No Abstract] [Full Text] [Related]
4. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism.
Finkel DM; Phillips JL; Snyder PJ
N Engl J Med; 1985 Sep; 313(11):651-5. PubMed ID: 3927163
[TBL] [Abstract][Full Text] [Related]
5. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism.
Shoham Z; Conway GS; Ostergaard H; Lahlou N; Bouchard P; Jacobs HS
Fertil Steril; 1992 May; 57(5):1044-51. PubMed ID: 1572472
[TBL] [Abstract][Full Text] [Related]
6. Gonadotropin therapy of men with hypogonadotropic hypogonadism.
Bhasin S; Salehian B
Curr Ther Endocrinol Metab; 1997; 6():349-52. PubMed ID: 9174768
[No Abstract] [Full Text] [Related]
7. Evaluation of gonadotropin-replacement therapy in male patients with hypogonadotropic hypogonadism.
Ortac M; Hidir M; Salabas E; Boyuk A; Bese C; Pazir Y; Kadioglu A
Asian J Androl; 2019; 21(6):623-627. PubMed ID: 31062720
[TBL] [Abstract][Full Text] [Related]
8. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
Liu L; Banks SM; Barnes KM; Sherins RJ
J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadotropic hypogonadism: gonadotropin therapy.
Snyder PJ
Curr Ther Endocrinol Metab; 1994; 5():300-3. PubMed ID: 7704739
[No Abstract] [Full Text] [Related]
10. Clinical and laboratory findings during gonadotropin therapy of post pubertal hypogonadotropic hypogonadism.
Smith KD; Ficher M; Steinberger E
Andrologia; 1974; 6(2):147-54. PubMed ID: 4421008
[No Abstract] [Full Text] [Related]
11. Absence of effect of recombinant growth hormone to classic gonadotropin treatment on spermatogenesis of patients with severe hypogonadotropic hypogonadism.
Giagulli VA
Arch Androl; 1999; 43(1):47-53. PubMed ID: 10445104
[TBL] [Abstract][Full Text] [Related]
12. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and/or maintain spermatogenesis in men with hypogonadotropic hypogonadism.
Schaison G; Young J; Pholsena M; Nahoul K; Couzinet B
J Clin Endocrinol Metab; 1993 Dec; 77(6):1545-9. PubMed ID: 8263139
[TBL] [Abstract][Full Text] [Related]
13. Human ovarian response to gonadotrophins with different ratios of follicle-stimulating hormone: luteinizing hormone assessed by different parameters.
Bertrand PV; Coleman JR; Crooke AC; Macnaughton MC; Mills IH
J Endocrinol; 1972 May; 53(2):231-48. PubMed ID: 5024053
[No Abstract] [Full Text] [Related]
14. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy following treatment with human gonadotropins in primary unexplained infertility.
Wang CF; Gemzell C
Acta Obstet Gynecol Scand; 1979; 58(2):141-6. PubMed ID: 582232
[TBL] [Abstract][Full Text] [Related]
16. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
[TBL] [Abstract][Full Text] [Related]
17. Pulsatile GnRH or human chorionic gonadotropin/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases.
Büchter D; Behre HM; Kliesch S; Nieschlag E
Eur J Endocrinol; 1998 Sep; 139(3):298-303. PubMed ID: 9758439
[TBL] [Abstract][Full Text] [Related]
18. Male hypogonadotropic hypogonadism: factors influencing response to human chorionic gonadotropin and human menopausal gonadotropin, including prior exogenous androgens.
Ley SB; Leonard JM
J Clin Endocrinol Metab; 1985 Oct; 61(4):746-52. PubMed ID: 3928676
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism.
Burgués S; Calderón MD
Hum Reprod; 1997 May; 12(5):980-6. PubMed ID: 9194651
[TBL] [Abstract][Full Text] [Related]
20. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
